ROSSI, LUIGIA
 Distribuzione geografica
Continente #
NA - Nord America 11.681
EU - Europa 7.208
AS - Asia 3.031
OC - Oceania 31
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 17
SA - Sud America 12
Totale 21.999
Nazione #
US - Stati Uniti d'America 11.640
GB - Regno Unito 3.035
CN - Cina 2.018
UA - Ucraina 1.262
IT - Italia 840
SE - Svezia 722
FI - Finlandia 457
TR - Turchia 451
DE - Germania 374
IE - Irlanda 280
SG - Singapore 241
JP - Giappone 111
KR - Corea 59
FR - Francia 57
IN - India 54
RU - Federazione Russa 51
CA - Canada 34
AU - Australia 29
BE - Belgio 25
PK - Pakistan 22
PL - Polonia 17
ES - Italia 16
EU - Europa 14
HK - Hong Kong 14
RO - Romania 14
IR - Iran 13
NL - Olanda 13
TG - Togo 12
AT - Austria 10
VN - Vietnam 8
KZ - Kazakistan 6
SA - Arabia Saudita 6
BR - Brasile 4
CH - Svizzera 4
CZ - Repubblica Ceca 4
NO - Norvegia 4
PT - Portogallo 4
ZA - Sudafrica 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CL - Cile 3
DK - Danimarca 3
LK - Sri Lanka 3
MX - Messico 3
TW - Taiwan 3
AM - Armenia 2
BD - Bangladesh 2
BG - Bulgaria 2
EC - Ecuador 2
GR - Grecia 2
ID - Indonesia 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PA - Panama 2
PE - Perù 2
RS - Serbia 2
SM - San Marino 2
TH - Thailandia 2
BY - Bielorussia 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
SI - Slovenia 1
Totale 21.999
Città #
Southend 2.825
Fairfield 1.692
Woodbridge 1.548
Houston 1.074
Jacksonville 1.010
Ann Arbor 892
Chandler 741
Ashburn 710
Cambridge 653
Seattle 642
Wilmington 578
Nanjing 541
Izmir 348
Dublin 278
Boardman 266
Nanchang 229
Urbino 213
Helsinki 188
Singapore 187
San Mateo 167
Beijing 153
Princeton 150
Shenyang 124
Hebei 120
New York 110
Jiaxing 98
Tianjin 92
Changsha 83
Düsseldorf 68
Istanbul 68
Kunming 61
San Diego 61
Mülheim 57
Bremen 55
Seongnam 50
Jinan 48
Shanghai 41
San Francisco 40
Guangzhou 37
Zhengzhou 37
London 34
Santa Clara 34
Hangzhou 32
Munich 31
Velikiy Novgorod 31
Los Angeles 30
Ningbo 27
Toronto 26
Brussels 24
Changchun 23
Taizhou 21
Des Moines 19
Bologna 18
Auburn Hills 17
Redwood City 16
Leawood 14
Rawalpindi 14
Fano 13
Rome 13
Alexandria 12
Augusta 12
Kraków 12
Lanzhou 12
Lomé 12
Norwalk 12
Canberra 11
Haikou 10
Melbourne 10
Wuppertal 10
Seoul 9
Venice 9
Dong Ket 8
Macerata 8
Pesaro 8
Copparo 7
Islington 7
Orange 7
Shenzhen 7
Ancona 6
Montemarciano 6
Portland 6
Riyadh 6
Vienna 6
Alatri 5
Amsterdam 5
Astana 5
Cava De' Tirreni 5
Centro 5
Chiswick 5
Florence 5
Frankfurt am Main 5
Hong Kong 5
Lahore 5
Mangalore 5
Osimo 5
Rimini 5
Rockville 5
Stockholm 5
Torre Del Greco 5
Washington 5
Totale 17.070
Nome #
Reengineering red blood cells for cellular therapeutics and diagnostics 279
Label-free quantification of Tacrolimus in biological samples by atomic force microscopy 214
A new therapy prevents intellectual disability in mouse with phenylketonuria 214
Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution 208
Red Blood Cell-Based Delivery of Drugs and Nanomaterials for Therapeutic and Diagnostic Applications 207
Pharmacokinetic and antiretroviral activity in mice of oral [P(1),P(2)-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine 207
Ex vivo encapsulation of dexamethasone sodium phosphate into human autologous erythrocytes using fully automated biomedical equipment 206
Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5'-triphosphate 204
Cytotoxic activity of 2-Fluoro-ara-AMP and 2-Fluoro-ara-AMP-loaded erythrocytes against human breast carcinoma cell lines. 204
A NONLINEAR THREE-COMPARTMENT MODEL FOR THE ADMINISTRATION OF 2’, 3’- DIDEOXYCYTIDINE BY USING RED BLOOD CELLS AS BIOREACTORS 204
Inhibition of murine AIDS by a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphonomethoxypropyl)adenine 203
Dexamethasone improves redox state in ataxia telangiectasia cells by promoting an NRF2-mediated antioxidant response 201
Human red blood cells as bioreactors for the release of 2', 3'-dideoxycytidine, an inhibitor of HIV infectivity. 199
In vivo effects of dexamethasone on blood gene expression in ataxia telangiectasia 199
Erythrocyte-based drug delivery 196
Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood Cells 196
Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS (MAIDS) 195
Immunophilin-loaded erythrocytes as a new delivery strategy for immunosuppressive drugs 193
Drug delivery through phagocytosis of red blood cells 191
Ultrastructural analysis of pancreatic acinar cells from mice fed on genetically modified soybean 190
2',3'-Dideoxycytidine metabolism in a new drug-resistant cell line 190
Inhibition of murine AIDS by reduced glutathione. 189
2',3'-Dideoxycytidine induced drug resistance in human cells 188
Red blood cells as advanced drug delivery systems for antiviral nucleoside analogues 188
Erythrocytes as a controlled drug delivery system: clinical evidences 188
Improved cellular uptake of functionalized single-walled carbon nanotubes 186
Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of lamivudine and tenofovir 185
Prolonged islet allograft survival in diabetic mice upon macrophage depletion by clodronate-loaded erythrocytes 184
Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir 184
Erythrocyte-mediated delivery of phenylalanine ammonia lyase for the treatment of phenylketonuria in BTBR-Pahenu2 mice 182
Acetaldehyde, ethanol and acetone concentrations in blood of alcohol-treated mice receiving aldehyde dehydrogenase-loaded erythrocytes 178
ATM splicing variants as biomarkers for low dose dexamethasone treatment of A-T 177
A new acyclic heterodinucleotide active against human immunodeficiency virus and herpes simplex virus 176
Drug delivery by red blood cells 176
Targeting nucleotide dimers containing antiviral nucleosides 174
Targeting antiviral nucleotide analogues to macrophages 174
Acyclovir prodrug and its use in pharmaceutical compositions 171
Approaches to erythrocyte-mediated drug delivery 171
Acetaldehyde dehydrogenase-loaded erythrocytes as bioreactors for the removal of blood acetaldehyde 170
Use of nonvolatile buffers in liquid chromatography/mass spectrometry: advantages of capillary-scale particle beam interfacing 170
Adherence and intracellular survival within human macrophages of Enterococcus faecalis isolates from coastal marine sediment 170
Drug delivery systems 169
Erythrocyte-mediated delivery of recombinant enzymes 168
Observation of erythrocyte dynamics in the retinal capillaries and choriocapillaris using ICG-loaded erythrocyte ghost cells 167
In vivo accelerated acetaldehyde metabolism using acetaldehyde dehydrogenase-loaded erythrocytes 167
Macrophage protection by nucleoside and nucleotide analogue administration 167
Role and mechanism of hexokinase decay during reticulocyte maturation and cell aging 167
REVERSED-PHASE LIQUID CHROMATOGRAPHIC DETERMINATION OF 2’, 3’-DIDEOXYCYTIDINE IN HUMAN BLOOD SAMPLES 166
Erythrocyte-mediated delivery of dexamethasone in patients with mild-to-moderate ulcerative colitis, refractory to mesalamine: a randomized, controlled study 166
Red Blood Cell Membrane Processing for Biomedical Applications 166
Human red blood cells as bioreactors for the release of 2',3'-dideoxycytidine, an inhibitor of HIV infectivity. 165
Human red blood cells as bioreactors for the release of 2',3'-dideoxycytidine, an inhibitor of HIV infectivity 164
null 164
Inhibition of murine AIDS by combination of AZT and DDCTP-loaded erythrocytes 163
Activation of NRF2 by dexamethasone in ataxia telangiectasia cells involves KEAP1 inhibition but not the inhibition of p38 163
Membrane-bound immunoglobulins increase during red blood cell aging. 161
Fine distribution of CLOCK protein in hepatocytes of hibernating dormice. 161
Normalization of hyperglycemia in diabetic mice by enzyme-loaded erythrocytes 161
In vivo accelerated acetaldehyde metabolism using acetaldehyde dehydrogenase-loaded erythrocytes. 159
Effect of age on some properties of mice erythrocytes 158
Efficacy and toxicity of long-term administration of 2',3'-dideoxycytidine in the LP-BM5 murine-induced immunodeficiency model 157
FIV infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine-5'-triphosphate. 155
Acetaldehyde oxidation by aldehyde dehydrogenase-loaded erythrocytes. 155
Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides 153
Effect of listeriolysin O-loaded erythrocytes on Mycobacterium avium replication within macrophages 153
Synthesis and biological application of a new heterodinucleotide with both anti-HSV and anti-HIV activity 152
Effect of phenylhydrazine on red blood cell metabolism. 152
Metabolism, mitochondrial uptake and toxicity of 2’,3’-dideoxycytidine 150
2',3'- Dideoxycytidine permeation of the human erythrocyte membrane. 149
Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions” PCT/EP 92/01291 148
Improved metabolic properties of hexokinase-overloaded human erythrocytes 147
Erythrocytes-mediated delivery of Dexamethasone in steroid-dependent IBD patients – A pilot uncontrolled study 147
Macrophage protection against human immunodeficiency virus or herpes simplex virus by red blood cell-mediated delivery of a heterodinucleotide of azidothymidine and acyclovir 146
An ex-vivo erythrocyte model for investigating oxidative metabolism 146
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 146
Inhibition of HIV-1 and LP-BM5 replication in macrophages by dideoxycytidine and dideoxycytidine 5'-triphosphate 145
Macrophage protection by nucleoside and nucleotide analogue administration 145
"Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions" 144
Synthesis, caracterization and erythrocyte encapsulation of an azidothymidine homodinucleotide 143
Red Blood Cell Loading: a Selection of Procedures 142
Preparation of glutathione derivatives as antiviral agents 142
Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus 141
Phagocytosis reduces HIV-1 production in human monocytes/macrophages infected in vitro. 140
Role of hexokinase in the regulation of erythrocyte hexose monophosphate pathway under oxidative stress 140
EFFECT OF PHENYLHYDRAZINE ON RED BLOOD CELL METABOLISM. 140
Red blood cell phagocytosis following hexokinase inactivation. 139
Heterodimer-loaded erythrocytes as bioreactors for slow delivery of the antiviral drug azidothymidine and the antimycobacterial drug ethambutol 138
Targeting antiviral nucleotide analogues to macrophages 138
ALCUNE PROPRIETÀ DI GLOBULI ROSSI UMANI SOTTOPOSTI A DIALISI IPOTONICA E RISIGILLAMENTO DA UTILIZZARE COME VEICOLI O BIOREATTORI. 137
Red blood cells as carriers of drugs against retroviruses 137
Effect of antiviral treatments on the bone marrow in murine AIDS 136
Erythrocytes as carriers of reduced glutathione (GSH) in the treatment of retroviral infections 136
Macrophage uptake of SWNT-COOC18H37 derivatives coated by phosphatidylethanolamine or phosphatidylserine 135
In vitro and in vivo toxicity of 2',3'-dideoxycytidine in mice 135
Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphonomethoxypropyl)adenine 132
New synthetic glutathione derivatives with increased antiviral activities 131
Modulated red blood cell survival by membrane protein clustering 131
Preclinical evaluation of an innovative anti-TAM approach based on zoledronate-loaded erythrocytes 131
Low doses of dexamethasone constantly delivered by autologous erythrocytes slow the progression of lung disease in cystic fibrosis patients 131
Red blood cells as an antigen-delivery system. 130
Totale 16.698
Categoria #
all - tutte 70.687
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.687


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.478 0 0 0 1.260 215 360 412 361 275 270 153 172
2020/20212.854 97 241 184 307 249 230 184 226 355 242 389 150
2021/20221.667 140 130 171 219 69 59 66 95 124 119 32 443
2022/20232.462 301 107 40 244 247 530 7 177 435 122 161 91
2023/2024699 77 74 47 89 56 143 21 26 8 87 7 64
2024/2025903 137 134 595 37 0 0 0 0 0 0 0 0
Totale 22.282